| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |